TSXV/NGMD (TSXV/NGMD)

TSX Venture Exchange: TSXV/NGMD · CAD

CA$0.02

+0.00 (0.0%)· Recorded snapshot

Market cap	3.4M
Revenue (ttm)	148.7K
Net income (ttm)	-9M
EPS (ttm)	-CA$0.04
Shares out	227M
Volume	0
Beta	1.53

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 148.7K
Net income (ttm): -9M
EPS (ttm): -CA$0.04
Market cap: 3.4M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11P50 16.8P75 23.9

Trailing P/En/a

P25 9.9P50 23.3P75 38.5

ROEn/a

P25 -104.1P50 -30P75 6.7

ROIC-45.3

P25 -55.9P50 -12.1P75 5

Benchmarks · 1M

All TSXV/NGMD indicators

Market & fundamental data

Available fields

146

Groups with data

Currency

CAD

Showing 146 of 146 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-27
Enterprise value	CAD 19.5M
Exchange	TSX Venture Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Industry	Medical Devices
Is primary listing	Yes
ISIN number	CA67054F1009
Last earnings date	2025-11-28
Last refreshed	2026-10-29
Last stock split date	2021-11-08
Last stock split type	Reverse
Market cap	CAD 3.4M
Next earnings date	2026-11-27
Price	CAD 0.02
Price currency	CAD
Sector	Healthcare
SIC code	3841
Stock price date	2026-07-29
Symbol	tsxv/NGMD
Website	https://www.nugenmd.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-265.28%
EV/Sales	131.08x
FCF / EV yield	-23.05%
FCF yield	-131.92%
P/S ratio	22.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	47.83%
Operating margin	-2,992.62%
Pretax margin	-6,044.85%
ROA	-41.75%
ROA (5Y)	-41.05%
ROCE	259.23%
ROIC	-45.32%
Tax / revenue	29.8%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Gross profit growth	-87.4%
Gross profit growth (Q)	-78.9%
Gross profit growth 3Y	3.68%
Gross profit growth 5Y	-4.3%
Revenue growth	-86.31%
Revenue growth (Q)	-76.92%
Revenue growth (QoQ)	-79.31%
Revenue growth 3Y	26.82%
Revenue growth 5Y	2.95%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -302,313
Depreciation and amortization	CAD 405,041
EBIT	CAD -4.5M
EBITDA	CAD -4M
EPS	CAD -0.04
FCF per share	CAD -0.02
Free cash flow	CAD -4.5M
Gross profit	CAD 71,132
Income taxes	CAD 44,316
Investing cash flow	CAD -533,104
Net cash flow	CAD -4.7M
Net income	CAD -9M
Operating income	CAD -4.5M
Revenue	CAD 148,721

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-37.59
Book value per share	CAD -0.08
Interest coverage	-1.27
Long-term assets	CAD 585,757
Long-term liabilities	CAD 15.4M
Net cash (debt)	CAD -17.9M
Net cash / market cap	-526.22%
Piotroski F-Score	2
Property, plant and equipment	CAD 585,757
Shareholders' equity	CAD -17.1M
Tangible book value	CAD -17.1M
Tangible book value per share	CAD -0.08
Total assets	CAD 2M
Total cash	CAD 700,773
Total debt	CAD 18.6M
Total liabilities	CAD 19.2M
WACC	14.51%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.02
Current assets	CAD 1.5M
Current liabilities	CAD 3.8M
Current ratio	0.39
Inventory turnover	0.19
Net working capital	CAD 220,553
Quick ratio	0.22
Working capital	CAD -2.3M
Working capital turnover	0.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2%
Shareholder yield	-2%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.03
1D price change	0%
1M price change	-25%
1M total return	-25%
1Y price change	-72.73%
1Y return CAGR	-72.75%
1Y total return	-72.73%
20-day SMA	CAD 0.02
200-day SMA	CAD 0.04
3M price change	-40%
3M total return	-40%
3Y price change	-91.67%
3Y return CAGR	-56.31%
3Y total return	-91.67%
50-day SMA	CAD 0.02
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.06
52-week high date	2025-09-30
52-week low	CAD 0.02
52-week low date	2026-07-29
6M price change	-50%
6M total return	-50%
All-time high	CAD 0.53
All-time high date	2021-11-10
All-time low	CAD 0.02
All-time low date	2026-04-08
Average true range (ATR)	CAD 0.00
Average volume	89.7K
Beta (1Y)	-0.36
Beta (2Y)	-0.31
Beta (5Y)	1.53
Change from 52-week high	-75%
Change from 52-week low	0%
Change from all-time high	-97.17%
Change from all-time low	0%
Monthly RSI	31.13
Previous close	CAD 0.02
Price vs 150-day SMA	-51.3%
Price vs 20-day SMA	-21.05%
Price vs 200-day SMA	-58.45%
Price vs 50-day SMA	-32.13%
Relative volume	2.9
RSI	43.31
Sharpe ratio	0.22
Sharpe ratio (3Y)	0.01
Sortino ratio	0.39
Sortino ratio (3Y)	0.07
Volume	0
Weekly RSI	29.11
YTD price change	-50%
YTD total return	-50%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	221.6M
Shares change (QoQ)	0%
Shares change (YoY)	2%
Shares held by insiders	2.39%
Shares outstanding	227M

Deeper analysis on TSXV/NGMD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/NGMD report

Is a complete TSXV/NGMD research report available?

No complete published report is available for tsxv/NGMD (TSXV/NGMD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/NGMD (TSXV/NGMD)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/NGMD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/NGMD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSXV/NGMD

Frequently asked questions